Margaret Gatti-Mays, Deputy Director of Division of Medical Oncology Section Chief, Breast Medical Oncology Associate Professor at The Ohio State University, shared a post on LinkedIn:
“Periodically we need to pause in oncology and re-evaluate if the standard operating procedure is still the best approach.
Proud to be part of this collaboration that shows premedications can be safely omitted after 2 uneventful doses of paclitaxel.”
Title: Safely Stopping Premedications in Patients Receiving Paclitaxel: A Randomized Trial
Authors: Michael Berger, Maryam Lustberg, Paul J. Novotny, Nicole Williams, Ashley Pariser Davenport, Robert Wesolowski, Margaret E. Gatti-Mays, Jenna Cody, Charles L. Loprinzi, Daniel S. Childs
Read The Full Article
Other articles featuring Margaret Gatti-Mays on OncoDaily.